Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia

inhaled nitric oxide will be administered starting at 20 ppm. Treatment will continue for 14 days or until resolution of pulmonary hypertension

placebo will be administered starting at 20 ppm. Treatment will continue for 14 days or until resolution of pulmonary hypertension